DF/BWCC in clinical affiliation with South Shore Hospital

South Weymouth, Massachusetts 02190

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, HER2-negative Breast Cancer, HR-Positive Breast Cancer, Invasive Breast Cancer, Metastatic Breast Cancer, PD-L1 Negative, Triple Negative Breast Cancer

Studies at this site

• Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC — Recruiting now
• Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) — Running, not enrolling
• Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC — Running, not enrolling
• Palbociclib After CDK and Endocrine Therapy (PACE) — Running, not enrolling
• DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC — Running, not enrolling